GlassScriptPhysician profile
Christine Sticco
NPI 1144431610
$1,430.86
in general payments reported to CMS, 2019-2025
20 companies · $334 in 2025
The $334 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79.26 · 2020: $159 · 2021: $188 · 2022: $131 · 2023: $306 · 2024: $233 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $574 · Education: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $574.12 |
| Education | $299.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $489.45 | 2023-2025 | Veozah |
| Exeltis, USA INC. | $133.44 | 2020-2025 | Slynd |
| Glaxosmithkline, LLC. | $110.51 | 2019-2021 | |
| Millicent US INC | $89.44 | 2024-2025 | Intrarosa, Femlyv, Femring |
| Agile Therapeutics, INC. | $87.02 | 2021-2023 | Twirla |
| Myriad Women'S Health, INC. | $75.70 | 2023 | Myrisk |
| Myovant Sciences INC. | $66.10 | 2021-2022 | |
| Organon LLC | $60.64 | 2023-2025 | Nexplanon |
| Abbvie INC. | $52.76 | 2019-2021 | |
| Lupin INC. | $42.95 | 2019-2021 | |
| Evofem Biosciences, INC. | $42.88 | 2021-2025 | Phexxi, Solosec, Phexx |
| Sumitomo Pharma America, INC. | $31.79 | 2023-2024 | Myfembree |
| Philips North America LLC | $29.59 | 2020 | |
| Shield Therapeutics INC | $27.34 | 2022 | |
| Becton, Dickinson and Company | $18.33 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $16.10 | 2020 | |
| Therapeuticsmd, INC. | $15.90 | 2021 | |
| Circassia INC. | $14.67 | 2020 | |
| Merck Sharp & Dohme LLC | $13.82 | 2020 | |
| Coopersurgical, INC. | $12.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Sticco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.